BCL2L1 Antikörper (FITC)
Kurzübersicht für BCL2L1 Antikörper (FITC) (ABIN135022)
Target
Alle BCL2L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Mouse Anti-Bcl-xL-FITC
-
Spezifität
- Human/Mouse/Rat/Rhesus Bcl-xL
-
Produktmerkmale
- FITC Anti-Bcl-xL antibody for use in flow cytometry, immunohistochemistry / immunocytochemistry, and western blotting assays.
-
Immunogen
- Recombinant human Bcl-xS
-
Isotyp
- IgG3
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.1 mg/mL
-
Buffer
- Phosphate buffered saline containing < 0.1 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C
-
-
-
: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." in: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Andere Bezeichnung
- Bcl-xL
-
Hintergrund
-
Description: Mouse Anti-Bcl-xL-FITC
NCBI_Official_Symbol: BCL2L1, Bcl2l1, Bcl2l1, BCL2L1
Synoynms: Apoptosis regulator Bcl-X, Bcl-2-like 1 protein, BCL2L1
-
Gen-ID
- 598, 12048, 24888
-
UniProt
- Q07817
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Target
-